Category: Zacks Small Cap Research

1237210 / 716 POSTS
By Lisa ThompsonNYSE:MHH READ THE FULL MHH RESEARCH REPORT Mastech Digital (NYSE:MHH), based outside Pittsburgh, PA is an IT staffing business with a growing data and analytics consulting and project management service serving blue chip customers in ...
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Topline Data from Phase 3 ALS Trial Expected in 4Q20 BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is currently conducting a Phase 3 clinical trial of NurOwn® in pat ...
By Lisa ThompsonNASDAQ:TSEM READ THE FULL TSEM RESEARCH REPORT TowerJazz's (NASDAQ:TSEM) Q4 revenues came in below the midpoint of guidance, but within the guidance range, disappointing some. If one were to find a reason it would be due to less disc ...
By David Bautz, PhDTSX:MDNA.TO | OTC:MDNAF READ THE FULL MDNA.TO RESEARCH REPORT Financial Update On February 13, 2020, Medicenna Therapeutics Corp. (TSX:MDNA.TO) (OTC:MDNAF) announced financial results for the third quarter of fiscal year 2020 that ...
By David Bautz, PhDNASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT Financial Update On February 4, 2020, ContraFect announced a one-for-ten reverse stock split. We have updated this report to reflect this change. On December 17, 2019, ContraFect annou ...
NASDAQ:SNES SNES (NASDAQ:SNES) announced on February 13, 2020 the preliminary unaudited revenues for the fourth quarter of 2019. (Source: Shutterstock) The company reported approximately $70k in revenues, slightly lower than our estimates. Manageme ...
By David Bautz, PhDNASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT Additional Preclinical Data Presented on EPI-7386 On February 13, 2020, ESSA Pharma Inc. (NASDAQ:EPIX) announced additional preclinical data was presented at the 2020 American Society ...
By David Bautz, PhDNASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Soligenix, Inc. (NASDAQ:SNGX) is currently conducting a Phase 3 clinical trial of SGX301 in patients with cutaneous T cell lymphoma (CTCL). The FLASH (Fluorescent Light Activated Synth ...
By Ian Gilson, PhD, CFANASDAQ:SNES READ THE FULL SNES RESEARCH REPORT SenesTech (NASDAQ:SNES) announced on Feb. 13 2020 that unaudited revenue for 4Q19 would by about $0.07 million as compared to our estimate of $0.08 million. A goal of a reduction i ...
By Brian Marckx, CFANASDAQ:BMRA READ THE FULL BMRA RESEARCH REPORT Both the top and bottom lines of Biomerica’s (NASDAQ:BMRA) income statement were largely flat through the first six months of fiscal 2020 (ending October 31, 2019) as compared to the ...
1237210 / 716 POSTS